Feist-Weiller Cancer Center

Foundation for Women's Cancer website

The Chicago-based Foundation for Women’s Cancer will present a free seminar in Shreveport on Saturday, June 27, for survivors of gynecologic cancer.


Oncology experts from the Willis Knighton Health System and the Feist-Weiller Cancer Center will discuss topics such as gynecological testing, vaccination, and survivorship.  Most of the eight physicians leading the informational seminar come from Shreveport and New Orleans. The event will also educate friends and family members about the psychological and medical needs of cancer survivors.

Aired Thursday, May 7, at 6 p.m. Red River Radio's Health Matters with host Dr. Randall Brewer. Guests were Dr. James Hobley, gastroenterologist with GIS, and Dr. Roger Kim, Head of Minimally-Invasive Surgery, Feist-Weiller Cancer Center.  Topics will include GERD and other upper GI disorders.

Kate Archer Kent

Feist-Weiller Cancer Center in Shreveport is hosting a free oral, head and neck cancer screening this month.

The annual screening is now an 18-year tradition at Feist-Weiller. It coincides with April’s head and neck cancer awareness week, according to Dr. Vikas Mehta, an assistant professor of otolaryngology at LSU School of Medicine in Shreveport and director of head and neck robotic surgery at Feist-Weiller Cancer Center.

Kate Archer Kent

Feist-Weiller Cancer Center is starting a loaner hearing aid program for terminally ill cancer patients. All donated hearing aids will be loaned out to the patients who need them during the remaining months of their life. LSU Health Shreveport clinical audiologist Jessica Bever has fielded requests for spare hearing aids from physicians. Unused hearing aids are all around, according to Bever. It’s a matter of collecting them and creating a lending program.

Kate Archer Kent

Feist-Weiller Cancer Center in Shreveport is recruiting patients for a study underway in the United States and Australia that will follow 19,000 people who are 65 and older to look at the risk and benefits of an aspirin-a-day regimen. The placebo-controlled clinical trial will look at whether there are potential benefits for the prevention of heart disease, certain cancers and even dementia. But are the known risks of gastrointestinal bleeding and stroke too great? Dr. Gary Burton, clinical research director at Feist-Weiller, said it’s time to find out.